Subsequently, MM patients can generate spontaneous immune responses to a wide range of these MM-specific antigens, via tumor-infiltrating lymphocytes (TILs), especially CD4- and CD8-positive T-lymphocytes [14]. The gene discussed is CD4; the disease is Miyoshi myopathy.